Data collection in the Collaborative Wilms Tumour Africa Project by Israels, Trijn & Molyneux, Elizabeth
Data collection in the Collaborative Wilms Tumour Africa Project
Trijn Israels a, *, Elizabeth Molyneux b, the Collaborative Wilms Tumour Africa team
a Academy e Outreach and Department of Paediatric Oncology, Princess Maxima Center for Paediatric Oncology, Utrecht, the Netherlands
b Department of Paediatrics, College of Medicine, Blantyre, Malawi
a r t i c l e i n f o
Article history:
Received 22 April 2018
Received in revised form
28 August 2018









Data matters. Carefully collected and documented evidence
gives confidence to clinical management, is essential for the plan-
ning of future health needs and forms the basis of a cancer registry.
Data are the foundation on which protocols, prognostications,
follow up and supportive care are based; and data are only relevant
if appropriate to the children from the settings where the data are
collected. Evidence is also helpful in international collaborations to
inform others who have notworked in a similar setting. Proper data
is essential for adequate resource mobilization and distribution.
(see Figs. 1e5).
All clinical trials require careful documentation and can help
improve the care of children with cancer, including in sub-Saharan
Africa [1]. The Collaborative Wilms Tumour Africa Project is
implementing a consensus-adapted treatment guideline as a pro-
spective clinical trial with uniform outcome evaluation. This is
being undertaken in eight centres in Malawi, Cameroon, Ghana,
Zimbabwe and Ethiopia. Enrolment started in 2014. The project is
funded by World Child Cancer and the International Society of
Pediatric Oncology (SIOP). The overall aim is to increase survival to
more than 50% and to decrease both abandonment of treatment
and death during treatment to less than 10%. To understand and
thereby reduce deaths and decrease abandonment requires careful
and detailed documentation of the problems faced by families and
children with cancer in the setting in which the children are
treated. This project is collecting hospital-based data which can
answer questions about patient presentation to hospital and out-
comes of treatment. Population-based cancer registration is
necessary to understand the prevalence of cancers. Knowing how
common a cancer is would help us understand the lack or other-
wise failure of access to care. Unfortunately these registers are very
limited in sub-Saharan Africa.
We aim to achieve improved, long-term results by giving pri-
ority to interventions with most impact on childhood cancer care
and survival. Local teams decide on which interventions to priori-
tise and how to assess feasibility. We try to keep things as simple as
possible and to do ‘simple things' well. Additionally, we realize we
can only improve and implement interventions step by step. We
applied these same ‘principles' when developing and implement-
ing the data collection and management structure. Our systems for
data collection and data entry are simple but could be improved.
Data entry has to be checked centrally as double entry cannot be
done locally and data are transferred in a password controlled
dropbox. Improvements are possible in data monitoring, control
and electronic data entry; all require funding.
In March 2013, at the beginning of the collaborative project, a
three-day work meeting was held in Blantyre, Malawi. Team
leaders and the principal co-ordinator attended from Cameroon,
Accra (Ghana), Blantyre (Malawi) and Kampala (Uganda). Together,
we developed the treatment guideline, defined locally relevant
clinical questions and designed the case registration forms (CRFs).
Each individual item on the CRF was checked to decide whether it
should be included, and conclusions were by consensus agreement.
As a draft template we used the case record form of the SIOP
renal tumour study group that had been modified (simplified) for
use in Malawi. Pathologists and surgeons from each local centre
were asked to modify their sections as they saw fit. For example, at
the surgeons’ suggestion, the surgical section starts with a simple
question: ‘At operation does it look like a Wilms tumour: yes/no, if
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no e please specify’.
We sometimes had to find a good compromise. For example, we
wanted to document the size of the tumour at diagnosis and after
preoperative chemotherapy to assess the response. It was expected
that imaging techniques (ultrasonography, CT scan or MRI) with
reliable measurement of size would not always be available. Since
size was considered important enough to document we decided to
include an estimation of tumour size, as measured with a ruler, and
the clinician's assessment of response, although subjective.
The time spent together in designing the data entry form has
been a good investment. No data field is redundant and through
discussionwe obtained better insight into which data were feasible
to collect and what was too ambitious. Additionally, it enhanced
local ownership and active participation of individual centres and
their leaders.
We want to keep data entry simple and accessible. The CRFs are
in Microsoft Word. The local data entry person can complete the
form with pen and paper or complete a computerised soft copy.
Thereafter the forms are copied and collected centrally. Hard copies
can be sent by ordinary mail and soft copies can be sent by email or
placed in a dropbox. Transmitting soft copies by email or to a
dropbox are preferred. Site clinicians supervise and check the data
entry.
The person entering the data is more important than the data
collection system. Training is important, but it is mostly the dedi-
cation and interest of the person entering the data that determines
its quality and completeness. In our project the local clinical leaders
arrange who will enter the data. The local lead supervises and
checks all the forms before they are sent to the central co-ordinator.
In Blantyre the data entry person joins the ward rounds, knows all
the patients and coordinates the follow up.
Follow-up is challenging in low-income countries and especially
in sub-Saharan Africa. Parents have other priorities than returning
to the hospital with a healthy-looking child; funds are often lacking
for follow up and when they are available, bad roads and lack of
home addresses hamper outreach visits to the homes of patients.
Mobile phones are not always available and there is limited facility
for charging, as well as limited mobile phone network coverage in
Fig. 1. Archive of medical files in Blantyre, Malawi.
Fig. 2. The person is more important than the system - Dalida Pidini, data manager in
Blantyre, Malawi.
Fig. 3. A simple pen and paper system can work - admission book in Blantyre, Malawi.
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Fig. 4. Two pages of the case record form as an example.
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Fig. 4. (continued).
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rural areas. All of this means that survival data from low income
countries with longer term follow-up are rare. However long-term
follow-up is needed to record late relapses and establish the true
survival rate.
At the work meeting in 2013 we discussed and agreed on the
strategies to facilitate adequate long-term follow up in our project.
Personal details of the patient and his or her parents are carefully
documented at diagnosis. These include the home village, tradi-
tional authority and region. A home address is noted if available,
but many homes do not have an address and it is more important to
record landmarks near the home (e.g. a church, or a school) and
relevant mobile phone numbers, including phone numbers of rel-
atives or officials in the village. These details are essential when
active follow up by phone or by visiting the patient's home is
needed.
Someone in each centre is tasked to keep track of the patient
after active treatment is completed. An excel sheet is kept with the
names of all enrolled patients, the date they were last seen and
their condition (well or relapse of disease). This excel sheet
showing an overview of follow up is sent to the central coordinator
about every six months.
The central database is in SPSS. Two medical students are
helping to enter the data. They are familiar with SPSS and were
trained to understand the CRFs and the questions underlying the
different data points.
There are several challenges. Data entry, cleaning, integrating
and analysis all take time, and everyone involved in the project has
other duties, most often of patient care. It is a challenge to find time
to do the work. For a dedicated data manager, it is not always easy
to get good clinical supervision. In some centres it is a challenge to
get forms completed by other participating disciplines such as
pathology or surgery. However, as originally hoped for, overall this
multi-disciplinary project has strengthened local inter-disciplinary
activities.
The quality and completeness of the collected data has been
excellent; less than 10% of data points are unfilled and only a few
need clarifications by the central co-ordinating team. Careful pre-
project planning has meant that very few modifications or expla-
nations have been needed to assist data entry and completeness.
Good documentation will help to assess the true impact of in-
terventions in this regional network and will thus help to find
sustainable solutions for local challenges to benefit children with
cancer. Many of the lessons learned such as access to care, the need
for early and definitive diagnoses and the difficulty and cost of
follow up are all relevant to other chronic non-communicable
diseases that are of increasing concern and prominence in LMICs.
Perhaps the Wilms Collaborative Team Project can help to forge a
path for others to follow.
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Supplementary data related to this article can be found at
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